CSTL
Castle Biosciences, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:32:35 AM EST
34.01USD+1.902%(+0.63)35,856
CSTL Financials
In Q3 FY 2026 (ended ), Castle Biosciences, Inc. Common Stock (CSTL) reported revenue of $102.89M, net income of −$4.1M, operating cash flow of $19.74M, and assets of $579.41M (filed ).
Loading financial statements…